Manchester Central Convention Complex 2-3 September 2014
Cambridge, UK, 01 August 2014: ELRIG (European Laboratory Robotics Interest Group) today announced details of the programme for Drug Discovery 2014. Now in its 8th year, the conference and exhibition is the largest drug discovery meeting in the UK, and is expected to attract over 1000 delegates. The event provides an opportunity for scientists from all fields of early stage drug discovery to network throughout the two days, and to hear world class speakers present on the latest challenges, opportunities and advances. Registration for the event is free, and delegates can register online at www.elrig.org.
The 2014 event will feature a programme of scientific presentations, an exhibition area with around 100 vendor booths, networking opportunities, poster sessions, Dragons Den, Authors Workshop, Innovation Zone, Media Area and Careers Zone, and for the first time a series of Core Technologies Workshops, providing a more informal, interactive environment in which to discuss key issues and future directions, coordinated by leaders in their fields. There will be eight Scientific Sessions altogether, with three new sessions covering cutting-edge topics: Phenotypic Discovery & Cellular Imaging; Chemical Innovation in Lead Discovery; and Neuroscience Drug Targets.
The Scientific Sessions will feature presentations from leading scientists, including the show keynote address from Dr Susan Galbraith, Head of Oncology at AstraZeneca, on ‘Genetic drivers of cancer growth and resistance mechanisms’. Other speakers include: Lorenz Mayr, AstraZeneca; Daniela Gabriel, Novartis; Olli Kallioniemi, FIMM, Helsinki; Stefan Offermans, Max Planck; Dario Neri, ETH, Zurich; Lutz Jermuntas, MedImmune; and Eric Karran, Alzheimers Research UK.
For a full listing of speakers and sessions, visit http://elrig.org/drug-discovery-2014-overview/
In partnership with SLAS, this year’s conference will be preceded by a series of one day short courses, which will take place on Monday 1st September. For more information and to book a place, visit www.elrig.org/portfolio/slas-short-courses-drug-discovery-2014. The courses comprise:
• Course 1: Introduction to Laboratory Automation • Course 2: High Content Screening: Instrumentation, Assay Development, Screening, Image and Data Analysis • Course 3: Establishing Cell-Based Assays and Implementing 3D Culture Models for Screening and drug testing
Follow ELRIG on Twitter (@E_LRIG) and LinkedIn (www.linkedin.com/groups/ELRIG-2951734) for updates on this event, and more. The Twitter hashtag for the Drug Discovery event is #ELRIGDD14
About ELRIG
ELRIG is a rapidly growing not-for-profit special interest group focused on the use of robotics and associated technologies in the laboratory and also on the wider applications of laboratory automation. Membership consists of scientists, researchers, developers, engineers and business-people who are interested in robotics, automation and associated technological developments plus users and vendors of equipment and accessories in this field.
ELRIG’s primary objective is to provide an open communication forum for users and vendors, within which members can be educated, share information and experience and network with other members.
Contact
Katie Odgaard
Zyme Communications
Tel: +44 (0)7787 502 947
Email: katie.odgaard@zymecommunications.com
Twitter: zymecomms
Help employers find you! Check out all the jobs and post your resume.
